Study Stopped
Failure to recruit.
Sodium Restriction in the Management of Cirrhotic Ascites
Comparison of Efficacy of 2 Gram Versus 4 Gram Sodium Restriction in the Management of Cirrhotic Ascites
1 other identifier
interventional
68
1 country
1
Brief Summary
To determine the relationship between degree of sodium restriction and dietary compliance with clinical outcome of diuresis of portal hypertensive ascites in cirrhotic patients from a county hospital population. Primary objective: Demonstrate that, when accompanied by the appropriate diuretic regimen, a No Added Salt diet (4 grams sodium per day) is as effective as a Low Sodium diet (2 grams sodium per day) in the management of cirrhotic ascites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Oct 2007
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
October 22, 2007
CompletedFirst Posted
Study publicly available on registry
October 23, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedSeptember 14, 2010
September 1, 2010
2.2 years
October 22, 2007
September 10, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Control of ascites
3 months
Secondary Outcomes (1)
Patient acceptance and compliance
3 months
Study Arms (2)
1
EXPERIMENTAL4 gram sodium diet
2
ACTIVE COMPARATOR2 gram sodium diet
Interventions
Eligibility Criteria
You may qualify if:
- Cirrhotic patients of any etiology with ascites from portal hypertension diagnosed by paracentesis,
- Age 18-75
- Clinical or radiographic (abdominal CT or ultrasound) estimate of moderate - severe ascites
- Spanish-speaking subjects will be eligible for participation
You may not qualify if:
- Active drug or alcohol abuse,
- Active complications of SBP, hepatic encephalopathy, or GI bleed within 2 weeks,
- Hemorrhagic ascites, malignant ascites,
- Creatinine \>2 mg/dL or CCl \< 30 mL/min,
- K \> 5.5 mmol/L,
- Diuretic refractory ascites
- Allergy to or intolerance of either spironolactone or furosemide
- Homelessness, incarceration, inability to follow up in clinic, or comply with diet.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Parkland Memorial Hospital
Dallas, Texas, 75235, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jennifer A Cuthbert, M.D.
UT Southwestern Medical Center at Dallas
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 22, 2007
First Posted
October 23, 2007
Study Start
October 1, 2007
Primary Completion
December 1, 2009
Study Completion
September 1, 2010
Last Updated
September 14, 2010
Record last verified: 2010-09